BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Zhang H, He H, Li L, Li X, Zhang Y, Shao R. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma. Cancer Chemother Pharmacol 2013;72:777-88. [DOI: 10.1007/s00280-013-2253-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kaya Çakir H, Eroglu O. In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting. Iran J Basic Med Sci 2021;24:1515-22. [PMID: 35317122 DOI: 10.22038/IJBMS.2021.58393.12971] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Jacobs BAW, Pluim D, van der Laan P, Tzani A, Beijnen JH, Schellens JHM. Development and validation of a quantitative method for thymidine phosphorylase activity in peripheral blood mononuclear cells. Nucleosides Nucleotides Nucleic Acids 2018;37:436-54. [PMID: 30285552 DOI: 10.1080/15257770.2018.1498270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bera H, Chigurupati S. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer. European Journal of Medicinal Chemistry 2016;124:992-1003. [DOI: 10.1016/j.ejmech.2016.10.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
4 Kobashi N, Matsumoto H, Zhao S, Meike S, Okumura Y, Abe T, Akizawa H, Ohkura K, Nishijima K, Tamaki N, Kuge Y. The Thymidine Phosphorylase Imaging Agent 123 I-IIMU Predicts the Efficacy of Capecitabine. J Nucl Med 2016;57:1276-81. [DOI: 10.2967/jnumed.115.165811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li Z, Guo Y, Yu Y, Xu C, Xu H, Qin J. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip. Integr Biol 2016;8:1022-9. [DOI: 10.1039/c6ib00162a] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
6 Gao R, Li L, Shang B, Zhao C, Sheng W, Li D. A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma. Basic Clin Pharmacol Toxicol 2015;117:105-16. [PMID: 25615234 DOI: 10.1111/bcpt.12379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Alieva M, Ritsma L, Giedt RJ, Weissleder R, van Rheenen J. Imaging windows for long-term intravital imaging: General overview and technical insights. Intravital 2014;3:e29917. [PMID: 28243510 DOI: 10.4161/intv.29917] [Cited by in Crossref: 106] [Cited by in F6Publishing: 116] [Article Influence: 13.3] [Reference Citation Analysis]